leisure time -WSS

leisure time

author：focus 2025-08-04 03:43:21 - browse：41

Adam's take main illustration — Molly Ferguson/STAT

Cytokinetics was founded 26 years ago but has not yet developed a drug successfully to approval. That makes Tuesday’s Food and Drug Administration decision on its treatment for heart failure a big deal — except nearly everyone, even investors who own Cytokinetics — hopes the agency rules against it.

Hoping the FDA rejects the Cytokinetics drug, called omecamtiv mecarbil, is a relatively uncommon, up-is-down, down-is-up situation, but it makes sense in this case because the business and science of the drug are not aligned.

Consider: Cytokinetics shares rose in December when an outside group of experts convened by the FDA to examine omecamtiv’s benefits and risks recommended against the medicine’s approval. On Tuesday, the FDA is most likely to heed that advice and turn down the company’s marketing application.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Why are Kaiser Permanente staff considering a strike?

WSS

Senate HELP committee spars over health care workforce policies

Microbiome research is starting to find links to chronic diseases

Second xenotransplant done with gene

Second xenotransplant done with gene

Intarcia’s device

California man arrested in connection with serial murders of Mexican strip club workers

hotspot

leisure time

entertainment

How to save PrEP access — and even expand it

Hearing on Medicare drug price negotiation gets unusually heated

Jerome Adams on the need for new antivirals for Covid

How AI helped researchers track recovery from depression

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA panel to weigh approval of NurOwn, controversial ALS drug

The high cost of giving birth even with insurance

What Congress can do to address the rural doctor shortage

Dobbs anniversary: the lost opportunity of abortion as health care

UPS workers' union leader explains what's at stake as strike edges closer

knowledge

It's been 20 years since Dolly the sheep. Where's my clone?

Biotech lab space demand falls sharply

Why Titanic fascinates society, still drawing tours to the wreckage

Why Titanic fascinates society, still drawing tours to the wreckage

Rare Northern Lights show in US this week: Where and how to see it

Intarcia’s device

focus

hotspot

hotspot

Wikipedia